Tatva Chintan IPO good or bad | Tatva Chintan IPO Date, Share Price, Company details & more

Tatva Chintan Pharma was incorporated as ‘Tatva Chintan Pharma Chem Private Limited’ pursuant to a certificate of incorporation dated June 12, 1996 issued by the Registrar of Companies, Gujarat and Dadra & Nagar Haveli at Ahmedabad (“RoC”). Thereafter, pursuant to the conversion of our Company to a public limited company, the name of our Company was changed to ‘Tatva Chintan Pharma Chem Limited’, and a fresh certificate of incorporation dated February 26, 2021 was issued to our Company by the RoC.

Tatva Chintan has two subsidiaries:
1. Tatva Chintan USA, Inc. (“TC USA”)
2. Tatva Chintan Europe B.V. (“TC Europe”)

They are a specialty chemicals manufacturing company engaged in the manufacture of a diverse portfolio of structure directing agents (“SDAs”), phase transfer catalysts (“PTCs”), electrolyte salts for super capacitor batteries and pharmaceutical and agrochemical intermediates and other specialty chemicals (“PASC”). Our Company is the largest and only commercial manufacturer of SDAs for zeolites in India. It also enjoys the second largest position globally.

Major events and milestones of Tatva Chintan

2013 – Attained turnover of ₹500.00 million

2015 – Attained turnover of ₹1 billion

2015 – Incorporation of Tatva Chintan USA Inc., a wholly owned Subsidiary of our Company

2015 – Set up warehousing facility in Netherlands

2018 – Set up R&D facility in Vadodara

2019 – Incorporation of Tatva Chintan Europe BV, a wholly owned Subsidiary of our Company

2020 – Attained total revenue of ₹2 billion

Tatva Chintan Company Financials

Also see : Upcoming IPOs in 2021-22 India

Tatva Chintan IPO Key Details

Tatva Chintan IPO Dates

Tatva Chintan IPO Min-Max Lot Size

Tatva Chintan IPO Promoter Holding